EP 1844023 A1 20071017 - QUINAZOLINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DIABETES AND OBESITY
Title (en)
QUINAZOLINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DIABETES AND OBESITY
Title (de)
CHINAZOLINDERIVATE ZUR BEHANDLUNG UND PRÄVENTION VON DIABETES UND OBESITAS
Title (fr)
DÉRIVÉS DE QUINAZOLINE POUR LE TRAITEMENT PROPHYLACTIQUE ET THÉRAPEUTIQUE DU DIABÈTE ET DE L'OBÉSITÉ
Publication
Application
Priority
- KR 2005004664 W 20051230
- KR 20040117708 A 20041231
Abstract (en)
[origin: WO2006071095A1] The present invention relates to novel quinazoline derivatives effective in lowering blood glucose level and body weight, and a medicine for treatment and/ or prevention of diabetes and/ or obesity, which comprises the compound as an active ingredient.
IPC 8 full level
C07D 239/94 (2006.01); A61K 31/517 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01)
CPC (source: EP KR)
A61K 31/517 (2013.01 - KR); A61P 3/04 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 239/74 (2013.01 - KR); C07D 239/88 (2013.01 - EP KR); C07D 239/93 (2013.01 - EP KR); C07D 239/94 (2013.01 - EP KR); C07D 401/12 (2013.01 - EP KR); C07D 403/04 (2013.01 - EP KR); C07D 403/12 (2013.01 - EP KR); C07D 405/06 (2013.01 - EP KR); C07D 405/12 (2013.01 - EP KR); C07D 413/12 (2013.01 - EP KR)
Citation (search report)
See references of WO 2006071095A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2006071095 A1 20060706; EP 1844023 A1 20071017; JP 2008526734 A 20080724; KR 20060079121 A 20060705
DOCDB simple family (application)
KR 2005004664 W 20051230; EP 05823851 A 20051230; JP 2007549270 A 20051230; KR 20050134722 A 20051230